ClinicalTrials.gov
public full text
Public Domain
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
The purpose of this research study is to investigate if RAD001 is an effective treatment for pancreatic cancer that has spread and not responded to treatment. Experiments have shown that RAD001 can prevent cells from multiplying. RAD002 has also been tested in laboratory experiments imitating cancer conditions and the results have been promising.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors#899717
- RAD001 in Advanced Sarcoma#918553
- RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms#801125
- TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer#853306
- Replication Data for: ERK PLAYS A CONSERVED DOMINANT ROLE IN THE HETEROGENEITY OF EPITHELIAL-MESENCHYMAL TRANSITION IN PANCREAS CANCER CELLS#1042152
Record · ID 839695
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive